CHC Healthcare Group (TPE:4164)
Taiwan · Delayed Price · Currency is TWD 48.15
+0.50 (1.05%)
Sep 30, 2025, 1:35 PM CST
CHC Healthcare Group Market Cap
CHC Healthcare Group has a market cap or net worth of 8.94 billion as of September 30, 2025. Its market cap has increased by 19.90% in one year.
Market Cap
8.94B
Enterprise Value
12.92B
Revenue
4.07B
Ranking
n/a
PE Ratio
47.51
Stock Price
48.15
Market Cap Chart
Since October 18, 2011, CHC Healthcare Group's market cap has decreased from 9.89B to 8.94B, a decrease of -9.60%. That is a compound annual growth rate of -0.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 8.94B | 28.22% |
| Dec 31, 2024 | 6.97B | -31.26% |
| Dec 29, 2023 | 10.15B | 44.21% |
| Dec 30, 2022 | 7.04B | 14.81% |
| Dec 30, 2021 | 6.13B | 3.09% |
| Dec 31, 2020 | 5.94B | 5.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 286.16B |
| PharmaEssentia | 189.36B |
| Bora Pharmaceuticals Co., LTD. | 84.40B |
| Lotus Pharmaceutical | 67.06B |
| Lumosa Therapeutics | 48.18B |
| Oneness Biotech | 32.14B |
| Polaris Group | 28.58B |
| Center Laboratories | 27.60B |